Global tobacco companies expanding oral nicotine products in 2026

Global Tobacco Companies Oral Nicotine Products 2026: Industry Expansion

Company News

Global Tobacco Companies Oral Nicotine Products 2026: Industry Expansion

Global tobacco companies oral nicotine products 2026 are becoming an increasingly important part of the international nicotine industry as major tobacco companies expand nicotine pouch portfolios, increase manufacturing capacity and invest in smoke-free product categories.

The shift comes as traditional cigarette volumes face long-term pressure in several markets, while oral nicotine pouches continue to gain market share. Recent developments from British American Tobacco (BAT), Philip Morris International (PMI) and Altria show how established tobacco companies are increasing their focus on oral nicotine products.

Tobacco Companies Increase Focus on Oral Nicotine

The global tobacco industry is undergoing a significant portfolio transformation.

Rather than relying exclusively on combustible cigarettes, major companies are increasingly developing and commercializing products across several smoke-free categories, including heated tobacco, e-vapor and oral nicotine products.

Philip Morris International says that smoke-free products represented 42% of its total global net revenues as of July 2026, while the company continues to expand its portfolio of heated tobacco, e-vapor and oral smokeless products.

BAT has also reported strong momentum in Modern Oral. In its first-half 2026 results, the company said Modern Oral revenue increased 65.9%, making it its largest New Category by revenue. BAT also reported a 39.2% volume share across its top Modern Oral markets.

Nicotine Pouches Become a Key Oral Category

Nicotine pouches are one of the most visible parts of the modern oral nicotine market.

These products generally contain nicotine, flavourings and other ingredients inside a pouch that is placed between the gum and cheek or upper lip. Unlike traditional snus, nicotine pouches do not contain tobacco leaf.

The category has expanded rapidly in several international markets.

The World Health Organization reported that retail sales of nicotine pouches exceeded 23 billion units in 2024, representing growth of more than 50% compared with the previous year.

This growth has encouraged established tobacco companies to invest more heavily in oral nicotine brands, product development and distribution.

BAT Expands Its Modern Oral Portfolio

British American Tobacco has positioned Modern Oral as a central component of its New Category strategy.

The company’s Velo portfolio has been a major driver of its recent performance. BAT reported that Modern Oral revenue increased 65.9% in the first half of 2026, while New Category revenue overall increased 18%.

BAT also reported that its Modern Oral category leadership strengthened during the first half of 2026.

The company said its planned rollout of Velo Max in Modern Oral was expected to further support its U.S. performance during the second half of the year.

The development demonstrates how major tobacco companies are increasingly using different product formats and nicotine strengths to compete in the expanding oral category.

Philip Morris Expands ZYN and Oral Nicotine

Philip Morris International has also placed nicotine pouches at the center of its smoke-free strategy.

Its ZYN brand has become a major part of the company’s oral nicotine portfolio, with products available in multiple markets.

In June 2026, the U.S. Food and Drug Administration issued Modified Risk Tobacco Product orders for 20 ZYN nicotine pouch products. PMI described the decision as the first MRTP orders granted for nicotine pouches.

The regulatory development represents an important milestone for the category in the United States, although it does not mean that nicotine pouches are treated identically in every country.

PMI is also increasing manufacturing capacity. In July 2026, the company announced plans to increase its investment in its Colorado manufacturing campus to approximately $1.2 billion by 2028, supporting production of ZYN nicotine pouches.

Altria Expands on! PLUS

Altria is another major tobacco company increasing its focus on oral nicotine products.

In March 2026, Altria announced the nationwide retail expansion of on! PLUS nicotine pouches, manufactured by its Helix Innovations business. The company said wholesale deliveries began March 16, with participating retailers expected to receive the products nationwide beginning March 23.

The on! PLUS portfolio includes different nicotine strengths and flavours, reflecting the broader industry trend toward product diversification.

Altria’s 2026 results also show the increasing importance of nicotine pouches within the U.S. oral category. During the first half of 2026, the company estimated that the nicotine pouch category represented 59.0% of the U.S. oral tobacco category, up from 50.4% a year earlier.

Why Are Tobacco Companies Moving Toward Oral Nicotine?

Several factors are contributing to the industry’s increased focus on oral nicotine.

Changing Consumer Preferences

Some adult nicotine consumers are looking for products that do not involve combustion or smoke.

Oral nicotine products provide companies with another category through which they can serve existing adult nicotine consumers.

Declining Traditional Cigarette Volumes

Traditional cigarette consumption has faced structural pressure in many developed markets.

For tobacco companies, expanding smoke-free categories provides an opportunity to diversify revenue streams as the cigarette market changes.

Product Innovation

Modern oral products can be developed across different:

  • Nicotine strengths
  • Flavour profiles
  • Pouch formats
  • Packaging configurations
  • Product sizes
  • Consumer-use experiences

This gives companies additional opportunities to differentiate products in competitive markets.

Manufacturing Investment

The increasing scale of the category is also driving investment in production facilities.

PMI’s expanded Colorado investment for ZYN manufacturing demonstrates the size of the manufacturing infrastructure being developed around oral nicotine products.

Competition Is Becoming More Intense

The growth of oral nicotine products is creating greater competition among established tobacco companies.

BAT has Velo, PMI has ZYN and Altria has on! and on! PLUS. Each company is developing its own product portfolio and market strategy.

This competition is increasingly focused on:

  • Product quality
  • Nicotine strengths
  • Flavour variety
  • Product innovation
  • Manufacturing scale
  • Retail distribution
  • Regulatory compliance
  • Brand positioning

As the category matures, companies may increasingly compete on product consistency, manufacturing efficiency and regulatory readiness rather than simply on brand recognition.

Regulation Is Becoming More Important

The rapid expansion of nicotine pouches is also attracting greater regulatory attention.

The World Health Organization published a 2026 report examining how major tobacco companies promote nicotine pouches and highlighted concerns involving nicotine levels, flavours, marketing practices and youth exposure.

This means the industry’s expansion is taking place alongside a more complex regulatory environment.

Different countries are taking different approaches to nicotine pouches. Some markets have established regulatory frameworks, while others are still determining how newer oral nicotine products should be classified and controlled.

For international tobacco companies, understanding individual market requirements is therefore becoming an increasingly important part of product development and commercialization.

Impact on the Global Nicotine Supply Chain

The expansion of oral nicotine products is also creating implications for the wider nicotine supply chain.

Manufacturers developing nicotine pouches and other oral formats require consistent raw materials and reliable specifications.

Important supply-chain considerations can include:

  • Nicotine purity
  • Batch-to-batch consistency
  • Certificate of Analysis
  • Technical specifications
  • Manufacturing standards
  • Traceability
  • Storage requirements
  • Quality-control procedures
  • Regulatory documentation

As large companies scale their oral nicotine portfolios, suppliers are likely to face increasing expectations around consistency, documentation and supply reliability.

Product Quality Becomes More Important

The expansion of the oral nicotine category is placing greater emphasis on quality management throughout the manufacturing process.

For formulators and manufacturers, consistent raw-material characteristics can be important when developing products at commercial scale.

Nicotine suppliers serving the B2B market therefore need to maintain robust quality systems and provide appropriate technical documentation to support customer quality-control and procurement processes.

Global Expansion Continues in 2026

The expansion of oral nicotine products is not limited to one geographic market.

Reuters reported in August 2026 that nicotine pouches had become a key growth focus for major tobacco companies, with companies looking beyond established U.S. and Scandinavian markets toward countries and regions including Britain, Poland, Asia, the Middle East and Africa.

However, market expansion does not mean that the same products or regulatory approaches can be transferred directly from one country to another.

Product classification, nicotine limits, marketing restrictions, age requirements, taxation and licensing rules can differ significantly between jurisdictions.

What to Watch in the Oral Nicotine Market

Several trends are likely to remain important as the industry moves through 2026:

1. Greater investment in nicotine pouches

Large tobacco companies are continuing to invest in production capacity and distribution.

2. Wider product portfolios

Companies are introducing additional strengths, flavours and product configurations.

3. Stronger competition

ZYN, Velo, on! and other oral nicotine brands are competing for market share across established and emerging markets.

4. Increased regulatory scrutiny

Governments and public-health organizations are paying greater attention to nicotine pouch marketing, product characteristics and youth access.

5. Manufacturing scale

Large investments in production infrastructure indicate that leading companies are preparing for continued demand in major markets.

Leave a Reply

Your email address will not be published. Required fields are marked *